相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States
Elissa Meites et al.
CLINICAL INFECTIOUS DISEASES (2021)
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
Darron R. Brown et al.
VACCINE (2021)
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
Hannah G. Rosenblum et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008-2016
Angela A. Cleveland et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2018
Peng-Jun Lu et al.
MMWR SURVEILLANCE SUMMARIES (2021)
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015
Angela A. Cleveland et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Identification of HPV genotypes causing cervical precancer using tissue-based genotyping
Rebecca Venetianer et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination
Alyssa M. Cornall et al.
VACCINE (2020)
Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard
Alyssa M. Cornall et al.
VACCINE (2020)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019
Laurie D. Elam-Evans et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014
Nancy M. McClung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination
Lauri E. Markowitz et al.
VACCINE (2019)
Human Papillomavirus-Attributable Cancers - United States, 2012-2016
Virginia Senkomago et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
Elissa Meites et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014
Elaine W. Flagg et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway
Berit Feiring et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Inverse-Probability-Weighted Estimation for Monotone and Nonmonotone Missing Data
BaoLuo Sun et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Joseph E. Tota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Joseph E. Tota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era
Vicki B. Benard et al.
JAMA ONCOLOGY (2017)
Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014
Elaine W. Flagg et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2016)
Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination
Joseph E. Tota et al.
PLOS ONE (2016)
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
David Mesher et al.
EMERGING INFECTIOUS DISEASES (2016)
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Mona Saraiya et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Melanie Drolet et al.
LANCET INFECTIOUS DISEASES (2015)
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Mona Saraiya et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
Susan Hariri et al.
CANCER CAUSES & CONTROL (2012)
HPV Genotypes in High Grade Cervical Lesions and Invasive Cervical Carcinoma as Detected by Two Commercial DNA Assays, North Carolina, 2001-2006
Susan Hariri et al.
PLOS ONE (2012)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Darron R. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
分享论文
